Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

[Regulatory requirements for software medical devices: Comparison between Europe, the United States, and Algeria].

PMID: 40480339 · 2026

JournalAnnales pharmaceutiques francaises
Year2026
PMID40480339

Abstract

Software Medical Device (SWMD) are essential digital tools used in the healthcare sector for various medical applications. Like any medical device, MDS are subject to strict and rigorous regulations that vary from country to country, aiming to ensure their quality, safety, and effectiveness. This study examines the regulation of SWMD and compares the definitions, classifications, and approval processes in Algeria, Europe, and the United States, pointing out the similarities and differences among

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.